Influenza A virus H5N1 vaccine - CSL

Drug Profile

Influenza A virus H5N1 vaccine - CSL

Alternative Names: Avian influenza (bird flu) virus vaccine - CSL; CSL-401; CSL444 (Pandemic ISCOMATRIX® Flu); H5N1 aluminium pandemic influenza vaccine - CSL; H5N1 pandemic influenza vaccine - CSL; Panvax

Latest Information Update: 16 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CSL
  • Class Influenza A virus H5N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H5N1 subtype

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-A-virus-H5N1-subtype(Prevention) in New Zealand (Parenteral, Injection)
  • 11 Dec 2008 Launched (CSL 401) for Influenza-A virus H5N1 subtype in Australia (Parenteral); first global launch
  • 11 Dec 2008 Registered (CSL 401) for Influenza-A virus H5N1 subtype in Singapore (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top